ArticleScientific reports2021

Genome-wide CRISPR/Cas9 screening in human iPS derived cardiomyocytes uncovers novel mediators of doxorubicin cardiotoxicity.

Valerie Sapp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.